|
|
Post by selluwud on Oct 28, 2020 19:28:46 GMT
|
|
|
|
Post by imz72 on Nov 2, 2020 2:36:29 GMT
Healios posted today its CFO Richard Kincaid's presentation at the annual Cell & Gene Meeting on the Mesa that was held virtually on October 12-16, 2020. _____________________________________________________________ 0:57-1:08: "We have two very strong near-term catalysts in the form of two clinical studies for ischemic stroke and ARDS. Both of these studies will complete full enrollment in the very near future." 4:15-4:20 (Re: Treasure): "We announced recently that we expect this trial to fully enroll patients this quarter so Q4." 6:03-6:08 (Re: One-Bridge): "We announced recently that we're about 90% enrolled in this study so we're going to finish this up very soon." 13:30-13:35 (Re: Nikon): "They're working closely with our partners in the US Athersys to prepare for commercial manufacturing of Multi-Stem in Japan." |
|
|
|
Post by tmfbmf on Nov 9, 2020 22:50:45 GMT
Cost/dose came down so Athersys ended up owing $ to Healios bc Healios already paid too much. Cost/dose was about $15.8k. Not sure what it came down to, but it seems to have had a big effect on earnings. $19M burn rate this Q. I expect that to come down for Q4. Also, notable that they only sold 395,000 shares to Aspire Capital at an average price of $2.77 per share in the third quarter of 2020, generating proceeds of $1.1 million. Shows confidence that they're willing to let the Cash on Hand drop precipitously without much dilution.
|
|
|
|
Post by imz72 on Nov 10, 2020 0:31:27 GMT
|
|
|
|
Post by imz72 on Nov 13, 2020 9:36:44 GMT
|
|
|
|
Post by lcd on Nov 13, 2020 16:00:12 GMT
I have been holding a pretty large position in ATHX for a couple of years now averaged around $2. I am comfortable holding my current position, but speculating on buying more just for a short-term runup, but I tend to do very poorly at timing runups. I expect a temporary bump when complete enrollments are announced and if they sign a deal in Europe, that would likely be a significant, permanent move up. Anyone else adding more in the near future?
|
|
|
|
Post by imz72 on Nov 13, 2020 17:18:51 GMT
I would have added if I could. Results of two pivotal trials are expected in Japan by mid-2021 while Athersys market cap is under $400 million.
Edit: I ended up buying 1,000 more shares before the close...
|
|
|
|
Post by tmfbmf on Nov 13, 2020 23:41:40 GMT
Hardy is about to have the ARDS trial fully enrolled, including 5 COVID pts. He might be angry at Athersys for their slow pace enrolling MACOVIA. I'm sure he would like some overseas data to bolster his applications to the PMDA just like Healios is providing data that will bolster our submissions to the FDA. (Just a guess. There's many possible reasons for the 13-D.)
|
|
|
|
Post by tmfbmf on Nov 13, 2020 23:56:21 GMT
Got an email response from Hardy. Glad to have him on the board!
---
Thanks for reaching out to me.
As you know I cannot say much about this but there are several issues out there as I describe in 13D.
I witnessed shareholders value has been destroyed and will de diminished by the lack of governance and oversight over the management.
I am sure that they would try to paint it in different way to avoid accusation from shareholders but I would like to stand for the shareholders of Athersys and fight for them.
My soul is always with the patients and shareholders.
Sincerely,
Hardy TS Kagimoto,MD
Chairman&CEO
Healios=Life Explosion
|
|
|
|
Post by CM kipper007 on Nov 14, 2020 5:06:22 GMT
Got an email response from Hardy. Glad to have him on the board! --- Thanks for reaching out to me. As you know I cannot say much about this but there are several issues out there as I describe in 13D. I witnessed shareholders value has been destroyed and will de diminished by the lack of governance and oversight over the management. I am sure that they would try to paint it in different way to avoid accusation from shareholders but I would like to stand for the shareholders of Athersys and fight for them. My soul is always with the patients and shareholders. Sincerely, Hardy TS Kagimoto,MD Chairman&CEO Healios=Life Explosion Wow! Hardy is one of the good guys for sure. |
|
|
|
Post by CM kipper007 on Nov 18, 2020 18:29:11 GMT
13D more infoSo this statement was filed. I am sure most of you are aware already if you use reddit. Personally I like to see what people say here as things are more focused without the bickering. I totally get why Hardy is upset and so am I. If anyone has shown me faith in MS, it is Hardy. He, like all of us here invested spoke with our investment. I am disapointed Gil is treating Hardy like this. I also, don't really understand the conflict of interest that is talked about. I understand Hardy would be selling the therapy to hospitals etc. But Athersys would also be selling the therapy too.
|
|
hort
Full Member
Posts: 111
|
Post by hort on Nov 18, 2020 19:27:22 GMT
13D more infoSo this statement was filed. I am sure most of you are aware already if you use reddit. Personally I like to see what people say here as things are more focused without the bickering. I totally get why Hardy is upset and so am I. If anyone has shown me faith in MS, it is Hardy. He, like all of us here invested spoke with our investment. I am disapointed Gil is treating Hardy like this. I also, don't really understand the conflict of interest that is talked about. I understand Hardy would be selling the therapy to hospitals etc. But Athersys would also be selling the therapy too. It’s an interesting dynamic. If these new board members are related to the purported partnership, then it is arguably a conflict for Hardy and could explain the situation to a degree. The timing is also interesting, as I think it could be argued that Hardy doesn’t like the partnership talk as it will considerably diminish his control over the company. Finally, folks were speculating that the shares to be sold to a new partner might come from Helios rather than newly issued shares (in exchange for lower royalties perhaps) so this 13D could enable that transfer of shares. Would appreciate your thoughts as always. |
|
|
|
Post by imz72 on Nov 18, 2020 22:13:56 GMT
13D more infoSo this statement was filed. I am sure most of you are aware already if you use reddit. Personally I like to see what people say here as things are more focused without the bickering. I totally get why Hardy is upset and so am I. If anyone has shown me faith in MS, it is Hardy. He, like all of us here invested spoke with our investment. I am disapointed Gil is treating Hardy like this. I also, don't really understand the conflict of interest that is talked about. I understand Hardy would be selling the therapy to hospitals etc. But Athersys would also be selling the therapy too. It's about money and control, not emotions. Hardy wants more of the first two IMO. There are many unknowns like what exactly is Hardy referring to by "operational execution" but I'm sure he has a plan and it will unfold in the near future. |
|
|
|
Post by tmfbmf on Nov 19, 2020 13:25:37 GMT
13D more infoSo this statement was filed. I am sure most of you are aware already if you use reddit. Personally I like to see what people say here as things are more focused without the bickering. I totally get why Hardy is upset and so am I. If anyone has shown me faith in MS, it is Hardy. He, like all of us here invested spoke with our investment. I am disapointed Gil is treating Hardy like this. I also, don't really understand the conflict of interest that is talked about. I understand Hardy would be selling the therapy to hospitals etc. But Athersys would also be selling the therapy too. This fight has been going on for a while. Healios is the biggest shareholder but Hardy got the least votes to remain on the board. Gil and Hardy will both say they're looking out for shareholders, but institutional ownership is on Gil's side. He runs the show. He developed the cells, tested them in animals, tested them in humans, convinced the FDA to agree on the mechanisms of action, patented the processes, patented the improvements to the MAPCs that could produce better or streamlined treatments in the future, produced the cells for Hardy, taught hospitals in Japan how to run the trials, worked with the PMDA on trial design, and he is helping Healios in their application for approval. What has Hardy done? Why should anyone believe he knows the way forward when Gil got us this far? If Hardy comes out with something specific, he could change my mind, but if we don't actually know what they're fighting about I'm on Gil's side. Gil is changing out the dead wood on the BOD. Hardy should have had some input, but I assume it was just an oversight by Gil. He never had to deal with a board member who actually wanted to do what a board member is supposed to do before. In the long run, I think it's good for us to have Hardy on the board. Edit: Just saw the Athersys reply and it shows Hardy is just looking for his own money. Doesn't want to pay his bills and is acting inappropriately toward other board members. He could get voted out next annual meeting. I hope he does. |
|
|
|
Post by CM kipper007 on Nov 19, 2020 23:10:49 GMT
13D more infoSo this statement was filed. I am sure most of you are aware already if you use reddit. Personally I like to see what people say here as things are more focused without the bickering. I totally get why Hardy is upset and so am I. If anyone has shown me faith in MS, it is Hardy. He, like all of us here invested spoke with our investment. I am disapointed Gil is treating Hardy like this. I also, don't really understand the conflict of interest that is talked about. I understand Hardy would be selling the therapy to hospitals etc. But Athersys would also be selling the therapy too. This fight has been going on for a while. Healios is the biggest shareholder but Hardy got the least votes to remain on the board. Gil and Hardy will both say they're looking out for shareholders, but institutional ownership is on Gil's side. He runs the show. He developed the cells, tested them in animals, tested them in humans, convinced the FDA to agree on the mechanisms of action, patented the processes, patented the improvements to the MAPCs that could produce better or streamlined treatments in the future, produced the cells for Hardy, taught hospitals in Japan how to run the trials, worked with the PMDA on trial design, and he is helping Healios in their application for approval. What has Hardy done? Why should anyone believe he knows the way forward when Gil got us this far? If Hardy comes out with something specific, he could change my mind, but if we don't actually know what they're fighting about I'm on Gil's side. Gil is changing out the dead wood on the BOD. Hardy should have had some input, but I assume it was just an oversight by Gil. He never had to deal with a board member who actually wanted to do what a board member is supposed to do before. In the long run, I think it's good for us to have Hardy on the board. Edit: Just saw the Athersys reply and it shows Hardy is just looking for his own money. Doesn't want to pay his bills and is acting inappropriately toward other board members. He could get voted out next annual meeting. I hope he does. I really hope he doesn't get voted out. I would like this relationship to be repaired and for them to work together. I see there were issues with money... why is that? Is Hardy just late, purposely doing it, doing it because Gil isn't delivering on something Hardy needs? There's still too many questions for me to have a real opinion of who is in the right... maybe they are both guilty of not looking after each other? |
|
hort
Full Member
Posts: 111
|
Post by hort on Nov 19, 2020 23:59:31 GMT
This fight has been going on for a while. Healios is the biggest shareholder but Hardy got the least votes to remain on the board. Gil and Hardy will both say they're looking out for shareholders, but institutional ownership is on Gil's side. He runs the show. He developed the cells, tested them in animals, tested them in humans, convinced the FDA to agree on the mechanisms of action, patented the processes, patented the improvements to the MAPCs that could produce better or streamlined treatments in the future, produced the cells for Hardy, taught hospitals in Japan how to run the trials, worked with the PMDA on trial design, and he is helping Healios in their application for approval. What has Hardy done? Why should anyone believe he knows the way forward when Gil got us this far? If Hardy comes out with something specific, he could change my mind, but if we don't actually know what they're fighting about I'm on Gil's side. Gil is changing out the dead wood on the BOD. Hardy should have had some input, but I assume it was just an oversight by Gil. He never had to deal with a board member who actually wanted to do what a board member is supposed to do before. In the long run, I think it's good for us to have Hardy on the board. Edit: Just saw the Athersys reply and it shows Hardy is just looking for his own money. Doesn't want to pay his bills and is acting inappropriately toward other board members. He could get voted out next annual meeting. I hope he does. I really hope he doesn't get voted out. I would like this relationship to be repaired and for them to work together. I see there were issues with money... why is that? Is Hardy just late, purposely doing it, doing it because Gil isn't delivering on something Hardy needs? There's still too many questions for me to have a real opinion of who is in the right... maybe they are both guilty of not looking after each other? Y’all see the mesoblast partnership? Given we are WAY ahead of Meso in ARDS we should pull a better deal IMO |
|
|
|
Post by selluwud on Nov 20, 2020 1:05:34 GMT
I really hope he doesn't get voted out. I would like this relationship to be repaired and for them to work together. I see there were issues with money... why is that? Is Hardy just late, purposely doing it, doing it because Gil isn't delivering on something Hardy needs? There's still too many questions for me to have a real opinion of who is in the right... maybe they are both guilty of not looking after each other? Y’all see the mesoblast partnership? Given we are WAY ahead of Meso in ARDS we should pull a better deal IMO Yes, the MESO deal would bode well for ATHX I would think?? finance.yahoo.com/news/mesoblast-enters-global-collaboration-development-221200341.html |
|
|
|
Post by tmfbmf on Nov 23, 2020 15:28:37 GMT
www.sec.gov/Archives/edgar/data/1368148/000134100420000463/sc13da7.htmMore vague complaints by Hardy. Gil was specific in his response. Hardy failed to address accusations about him not paying bills and trying to influence other board members to help him screw us shareholders. He continues his vague whining, which means what Gil wrote in his response was true. Hardy is a cancer. He has to go. We can't have someone this unethical on the BOD. The part about inspecting the books means he is trying to prove he doesn't owe what Gil says he owes. He's not looking out for shareholders. He's looking out for himself. Gil is looking out for us by not paying this character.
|
|
|
|
Post by imz72 on Nov 23, 2020 15:48:48 GMT
|
|
|
|
Post by tmfbmf on Nov 23, 2020 16:54:35 GMT
The lawsuit is more specific, but I believe Gil has previously responded to the main complaint. Hardy can't have access to certain information. Should he? Are they keeping too much from him? Athersys should respond to all the points soon. Hardy could change my mind if he would just point out something Athersys did that he would have voted against and it ended up hurting us. That would cause me to sell my shares. Filing a lawsuit to get access to the books seems like a temper tantrum, but the details are what matter. Maybe he'll find something in those records and we'll pay him some money for it. |
|
